View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
September 22, 2021

Trialbee collaborates with Castor to boost access to trials

The partners will facilitate diversified participation and improve health equity for decentralised and hybrid clinical trials.

Trialbee has entered a strategic collaboration with Castor to boost access to clinical trials, fast-track participant enrolment and improve patient engagement.

The partners also aim to bolster remote enrolment and reduce the burden on trial sites worldwide.

With their integration, Trialbee and Castor will enable sponsors to meet participant recruitment timelines with continuous access to all trial data.

The companies will accelerate enrolment and optimise trials via advanced data science and streamlined workflows for patient recruitment, data gathering and engagement.

In addition, the collaboration is expected to facilitate diversified participation while improving health equity for decentralised and hybrid clinical programmes worldwide.

Castor CEO and founder Derk Arts said: “We are excited to partner with Trialbee to improve patient engagement, as well as optimise patient diversity and study inclusivity with real-time insights around patient demographics across all recruitment channels.

“Our partnership provides sponsors a seamless decentralised and hybrid clinical trial solution to manage all their clinical trial touchpoints and expand inclusivity at a global scale.”

As trial designs increase in complexity, qualified participant enrolment and retention become difficult, noted Trialbee.

Industry estimates show that the amount of patient eligibility in trials has grown nearly 150% in the past ten years.

Therefore, life sciences companies are requiring a patient matching and enrolment platform to aid in managing the patient’s journey into a trial, as well as streamline enrolment outcomes.

Trialbee and Castor’s integrations are expected to allow trial sponsors to easily manage all trial touchpoints, without impacting data quality.

Trialbee CEO Matt Walz said: “Through our combined capabilities, clinical trials can deploy an end-to-end solution to simplify the patient journey, including early introductions to clinical trials, enrollment performance analytics, and remote data capture for decentralised clinical trials.”

In May 2021, Trialbee partnered with Worldwide Clinical Trials to bolster patient enrolment and streamline timelines for clinical trials across the world.

Related Companies

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU